MyAverix Finance
SHG · Healthcare
Zhejiang Starry Pharm Co Ltd (603520)
Drug Manufacturers - Specialty & Generic
Zhejiang Starry Pharm Co Ltd (603520) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $4.78B, P/E ratio is 18.00, net margin is -1.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603520
Zhejiang Starry Pharm Co Ltd (603520) — FAQ
What is Zhejiang Starry Pharm Co Ltd's market cap?
Zhejiang Starry Pharm Co Ltd (603520) has a reported market cap of $4.78B (data as of 2026-03-29).
What is 603520's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Starry Pharm Co Ltd (603520) is 18.00 (data as of 2026-03-29).
Does Zhejiang Starry Pharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Starry Pharm Co Ltd (603520). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Starry Pharm Co Ltd in?
Zhejiang Starry Pharm Co Ltd (603520) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603520 listed on?
603520 is listed on SHG.
What is Zhejiang Starry Pharm Co Ltd's net margin?
Zhejiang Starry Pharm Co Ltd (603520) reports a net margin of -1.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.